PAPER Kawamata J, Suzuki S, Shimohama S

Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.

Ther Adv Chronic Dis. 2011 May;2(3):197-208. PubMed.

PAPER Wilson D, Peters R, Ritchie K, Ritchie CW

Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia.

Ther Adv Chronic Dis. 2011 May;2(3):161-73. PubMed.

PAPER Mossello E, Ballini E

Management of patients with Alzheimer's disease: pharmacological treatment and quality of life.

Ther Adv Chronic Dis. 2012 Jul;3(4):183-93. PubMed.

PAPER Tampi RR, Tampi DJ, Balachandran S, Srinivasan S

Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses.

Ther Adv Chronic Dis. 2016 Sep;7(5):229-45. Epub 2016 Jul 15 PubMed.

PAPER Hosking DE, Ayton S, Beckett N, Booth A, Peters R

More evidence is needed. Iron, incident cognitive decline and dementia: a systematic review.

Ther Adv Chronic Dis. 2018;9(12):241-256. Epub 2018 Jul 23 PubMed.

PAPER Onoviran OF, Li D, Toombs Smith S, Raji MA

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.

Ther Adv Chronic Dis. 2019;10:2040622319862691. Epub 2019 Jul 12 PubMed.

PAPER Panza F, Lozupone M, Sardone R, Battista P, Piccininni M, Dibello V, La Montagna M, Stallone R, Venezia P, Liguori A, Giannelli G, Bellomo A, Greco A, Daniele A, Seripa D, Quaranta N, Logroscino G

Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life.

Ther Adv Chronic Dis. 2019;10:2040622318811000. Epub 2018 Nov 9 PubMed.

PAPER Yap TE, Balendra SI, Almonte MT, Cordeiro MF

Retinal correlates of neurological disorders.

Ther Adv Chronic Dis. 2019;10:2040622319882205. Epub 2019 Dec 2 PubMed.

PAPER Müller HP, Lulé D, Roselli F, Behler A, Ludolph AC, Kassubek J

Segmental involvement of the corpus callosum in C9orf72-associated ALS: a tract of interest-based DTI study.

Ther Adv Chronic Dis. 2021;12:20406223211002969. Epub 2021 Mar 21 PubMed.

PAPER Ji S, Zhao X, Zhu R, Dong Y, Huang L, Zhang T

Metformin and the risk of dementia based on an analysis of 396,332 participants.

Ther Adv Chronic Dis. 2022;13:20406223221109454. Epub 2022 Jul 9 PubMed.

PAPER Müller HP, Nagel AM, Keidel F, Wunderlich A, Hübers A, Gast LV, Ludolph AC, Beer M, Kassubek J

Relaxation-weighted 23Na magnetic resonance imaging maps regional patterns of abnormal sodium concentrations in amyotrophic lateral sclerosis.

Ther Adv Chronic Dis. 2022;13:20406223221109480. Epub 2022 Jul 8 PubMed.

PAPER Vecchio FL, Bisceglia P, Imbimbo BP, Lozupone M, Latino RR, Resta E, Leone M, Solfrizzi V, Greco A, Daniele A, Watling M, Panza F, Seripa D

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease?

Ther Adv Chronic Dis. 2022;13:20406223221081605. Epub 2022 Mar 17 PubMed.

PAPER Fan SM, Chiu PY, Liu CH, Liao YC, Chang HT

Predictive value of hypercholesterolemia, vegetarian diet, and hypertension for incident dementia among elderly Taiwanese individuals with low educational levels.

Ther Adv Chronic Dis. 2023;14:20406223231171549. Epub 2023 May 27 PubMed.

PAPER Clark S, Antell A, Kaufman K

New antiepileptic medication linked to blue discoloration of the skin and eyes.

Ther Adv Drug Saf. 2015 Feb;6(1):15-9. PubMed.

PAPER Stella F, Radanovic M, Canineu PR, de Paula VJ, Forlenza OV

Anti-dementia medications: current prescriptions in clinical practice and new agents in progress.

Ther Adv Drug Saf. 2015 Aug;6(4):151-65. PubMed.